Webinar: SARS-CoV-2 Total Antibody Immunoassay - Launch soon
01. Dec 2021 |
2 min read
SARS-CoV-2 Total Antibody Immunoassay - Soon on chemical analysers
In the effort to restrain the COVID-19 pandemic, serological testing to detect SARS-CoV-2 specific antibodies will be important in disease and community management.
Gentian has developed a turbidimetric SARS-CoV-2 Total Antibody Immunoassay in collaboration with the University in Tromsø (UiT), Norway, that will be launched soon. This quantitative antibody test captures the full immune response detecting antibodies targeting the S1 subunit with high sensitivity and specificity. It will be calibrated against the international WHO international standard.
Webinar: High-throughput SARS-CoV-2 Total Antibody Immunoassay
Learn more about our SARS-CoV-2 total antibody immunoassay that will be launched soon.
Get in touch for more information about the immunoassay
Let us know if you want more information about the assay or want to validate the assay in your laboratory at the time of launch.
Please send us an email to firstname.lastname@example.org or fill out the form to the right. Our Product Manager for SARS-CoV-2 Total Antibody Immunoassay will get in touch.